Catalyst Wire Dossier Catalyst Wire Dossier

Nacubactam

nacubactam · Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nacubactam, covering 2018-04-23 to 2018-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Intrapulmonary Lung Penetration of Nacubactam in Healthy Participants [Phase 1]

See pricing